Published in Cardiovascular Week, November 14th, 2011
"Seven neurologists and a clinimetrician assessed each scale's previous use and critiqued its clinimetric properties. A scale was 'recommended' if it had been applied to populations of patients with Parkinson's disease, with data on its use in studies beyond the group that developed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.